Hangzhou AGS MedTech Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	609.05	593.74	632.86	506.09	368.92	305.1
Other Revenue	-	-	3.78	2.65	2.2	0.37
Revenue	609.05	593.74	636.63	508.75	371.11	305.47
Revenue Growth (YoY)	-6.83%	-6.74%	25.14%	37.09%	21.49%	77.64%
Cost of Revenue	5.27	171.67	180.84	149.86	119.38	108.54
Gross Profit	603.77	422.07	455.79	358.89	251.73	196.92
Selling, General & Admin	-1.79	124.4	108.89	95.38	66.59	53
Research & Development	2.66	75.89	59.21	41.25	31.46	24.19
Other Operating Expenses	337.24	-2.03	6.09	1.39	3.29	2.43
Operating Expenses	337.5	198.26	173.69	140.17	101.63	79.83
Operating Income	266.28	223.81	282.11	218.72	150.1	117.09
Interest Expense	-0.05	-	-	-	-	-
Interest & Investment Income	6.39	36.97	55.23	28.91	2.59	2.52
Currency Exchange Gain (Loss)	-	-	0.32	0.69	11.1	-4.24
Other Non Operating Income (Expenses)	-7.78	1.07	1.19	-1.05	-0.84	-0.14
EBT Excluding Unusual Items	264.84	261.86	338.85	247.28	162.95	115.23
Gain (Loss) on Sale of Investments	2.07	2.51	2.08	0.41	-7.19	1.09
Gain (Loss) on Sale of Assets	-0.03	-0.05	-0.2	-0.8	-0.14	-0.01
Asset Writedown	-2.03	-2.27	-	-	-0	-0.14
Other Unusual Items	0.09	-	2.87	4.78	9.94	3.79
Pretax Income	264.94	262.05	343.6	251.67	165.56	119.97
Income Tax Expense	41.79	40.61	50.21	34.43	20.6	15.17
Earnings From Continuing Operations	223.15	221.44	293.39	217.24	144.96	104.8
Minority Interest in Earnings	0.22	0.28	-	-	-	-
Net Income	223.36	221.71	293.39	217.24	144.96	104.8
Net Income to Common	223.36	221.71	293.39	217.24	144.96	104.8
Net Income Growth	-24.76%	-24.43%	35.06%	49.86%	38.32%	131.68%
Shares Outstanding (Basic)	80	80	81	73	61	61
Shares Outstanding (Diluted)	80	80	81	73	61	61
Shares Change (YoY)	-0.40%	-0.13%	11.02%	19.46%	-	-
EPS (Basic)	2.78	2.76	3.64	2.99	2.39	1.72
EPS (Diluted)	2.78	2.75	3.64	2.99	2.39	1.72
EPS Growth	-24.46%	-24.33%	21.65%	25.44%	38.60%	131.71%
Free Cash Flow	-	87.74	266.19	169.88	96.26	102.59
Free Cash Flow Per Share	-	1.09	3.30	2.34	1.58	1.69
Dividend Per Share	-	-	1.373	1.036	0.543	-
Dividend Growth	-	-	32.62%	90.77%	-	-
Gross Margin	99.13%	71.09%	71.59%	70.54%	67.83%	64.47%
Operating Margin	43.72%	37.70%	44.31%	42.99%	40.45%	38.33%
Profit Margin	36.67%	37.34%	46.09%	42.70%	39.06%	34.31%
Free Cash Flow Margin	-	14.78%	41.81%	33.39%	25.94%	33.59%
EBITDA	-	237.37	290.07	225.29	154.82	121.17
EBITDA Margin	-	39.98%	45.56%	44.28%	41.72%	39.67%
D&A For EBITDA	-	13.56	7.96	6.56	4.72	4.07
EBIT	266.28	223.81	282.11	218.72	150.1	117.09
EBIT Margin	43.72%	37.70%	44.31%	42.99%	40.45%	38.33%
Effective Tax Rate	15.77%	15.50%	14.61%	13.68%	12.44%	12.64%
Revenue as Reported	11.84	-	636.63	508.75	371.11	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.